JP Morgan Chase’s PRA Health Sciences, Inc. PRAH Stock Holding History

JP Morgan Chase’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-75,000	Closed	-$5.69M	–	5651
2017 Q3	$5.69M	Buy	+75,000	New	+$5.67M	﹤0.01%	2464

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

JP Morgan Chase's PRAH Position: Q3 2021 in Review

JP Morgan Chase sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 697,656 shares — an estimated $115M sold.

JP Morgan Chase first reported a position in PRAH in Q4 2014 and held it in 23 quarters. The position peaked at $115M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

JP Morgan Chase reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
JP Morgan Chase sold 697,656 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $115M.
JP Morgan Chase first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 23 quarters.
JP Morgan Chase's PRA Health Sciences, Inc. position peaked at $115M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.